306 related articles for article (PubMed ID: 37190315)
1. Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy.
Nardone OM; Zammarchi I; Santacroce G; Ghosh S; Iacucci M
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190315
[TBL] [Abstract][Full Text] [Related]
2. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies.
Fantini MC; Guadagni I
Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800
[TBL] [Abstract][Full Text] [Related]
3. Advancements in Endoscopic Resection for Colitis-Associated Colorectal Neoplasia in Inflammatory Bowel Disease: Turning Visible into Resectable.
Maselli R; de Sire R; Massimi D; Franchellucci G; Busacca A; Castiglione F; Rispo A; Hassan C; Armuzzi A; Repici A
Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201318
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance.
Wang ZH; Fang JY
Gastrointest Tumors; 2014 Aug; 1(3):146-54. PubMed ID: 26674110
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation.
Rivera AP; Flores Monar GV; Islam H; Puttagunta SM; Islam R; Kundu S; Jha SB; Sange I
Cureus; 2022 Feb; 14(2):e22636. PubMed ID: 35371788
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
Kim ER; Chang DK
World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
[TBL] [Abstract][Full Text] [Related]
8. Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies.
Cassotta M; Cianciosi D; De Giuseppe R; Navarro-Hortal MD; Armas Diaz Y; Forbes-Hernández TY; Pifarre KT; Pascual Barrera AE; Grosso G; Xiao J; Battino M; Giampieri F
Nutrition; 2023 Jun; 110():111980. PubMed ID: 36965240
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives.
Majumder S; Shivaji UN; Kasturi R; Sigamani A; Ghosh S; Iacucci M
World J Gastrointest Oncol; 2022 Mar; 14(3):547-567. PubMed ID: 35321275
[TBL] [Abstract][Full Text] [Related]
10. Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia.
Iacucci M; Santacroce G; Majumder S; Morael J; Zammarchi I; Maeda Y; Ryan D; Di Sabatino A; Rescigno M; Aburto MR; Cryan JF; Ghosh S
Gut; 2024 Jun; ():. PubMed ID: 38851294
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
[TBL] [Abstract][Full Text] [Related]
12. The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival.
Vitali F; Wein A; Rath T; Eckstein M; Neufert C; Siebler J; Atreya R; Hartmann A; Hohenberger W; Weber K; Neurath MF; Grützmann R; Merkel S
Int J Colorectal Dis; 2022 Feb; 37(2):381-391. PubMed ID: 34865179
[TBL] [Abstract][Full Text] [Related]
13. Strategies for detecting colon cancer in patients with inflammatory bowel disease.
Bye WA; Nguyen TM; Parker CE; Jairath V; East JE
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD000279. PubMed ID: 28922695
[TBL] [Abstract][Full Text] [Related]
14. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.
Shah SC; Itzkowitz SH
Gastroenterology; 2022 Mar; 162(3):715-730.e3. PubMed ID: 34757143
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer in inflammatory bowel disease: review of the evidence.
Keller DS; Windsor A; Cohen R; Chand M
Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminosalicylic Acid Chemoprevention in Inflammatory Bowel Diseases: Is It Necessary in the Age of Biologics and Small Molecules?
Herfarth H; Vavricka SR
Inflamm Intest Dis; 2022 Jan; 7(1):28-35. PubMed ID: 35224015
[TBL] [Abstract][Full Text] [Related]
18. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
19. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
[TBL] [Abstract][Full Text] [Related]
20. Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data.
Pratt M; Forbes JD; Knox NC; Bernstein CN; Van Domselaar G
Front Cell Dev Biol; 2021; 9():716604. PubMed ID: 34869308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
